NCT02052154View on ClinicalTrials.gov

Multicenter Pilot Study Evaluating the Immunogenicity of an Innovative Pneumococcal Vaccination Strategy in Splenectomized Adults

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 10, 2014

Primary Completion Date

July 19, 2016

Study Completion Date

April 2, 2019

Conditions

Splenectomized Patients

Interventions

BIOLOGICAL

Prime-boost pneumococcal immunization

2 months between the 2 vaccines

Trial Locations (1)

75015

Service des Maladies Infectieuses et Tropicales - Centre d'Infectiologie Necker-Pasteur, IHU Imagine - Hôpital Necker-Enfants, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02052154 - Multicenter Pilot Study Evaluating the Immunogenicity of an Innovative Pneumococcal Vaccination Strategy in Splenectomized Adults | Biotech Hunter | Biotech Hunter